Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2296
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: a qualitative study ; volume:10 ; number:1 ; day:21 ; month:4 ; year:2009 ; pages:1-7 ; date:12.2009
BMC family practice ; 10, Heft 1 (21.4.2009), 1-7, 12.2009
- Creator
-
AB, Elisabeth
- Contributor
-
Denig, Petra
Vliet, Ton van
Dekker, Janny H.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2296-10-24
- URN
-
urn:nbn:de:1111-201602189122
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- AB, Elisabeth
- Denig, Petra
- Vliet, Ton van
- Dekker, Janny H.
- SpringerLink (Online service)
Other Objects (12)
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994–2003
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Initial non-adherence to lipid-lowering medication: a systematic literature review
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994–2003
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice
Initial non-adherence to lipid-lowering medication: a systematic literature review
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Lipid-lowering properties of protein-rich mucuna product
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons
Nicotinic acid: a lipid-lowering agent with unrealized potential
Ezetimibe as lipid-lowering therapy for patients receiving HAART
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994–2003
Effects of Lipid-Lowering Drugs Upon Fasting-Induced Platelet Aggregation
Cost-Effectiveness of Lipid-Lowering Therapies for Cardiovascular Prevention in Germany
Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice